Billy Wayne Ruddick Jr., Ph.D., is a character eerily reminiscent of someone we know, a distant relative who picks political fights on Facebook and Twitter.
FDA approved Magtrace and Sentimag Magnetic Localization System (Sentimag System), a magnetic device system for guiding lymph node biopsies in patients with breast cancer undergoing mastectomy. It uses magnetic detection during sentinel lymph node biopsy procedures to identify specific lymph nodes, known as sentinel lymph nodes, for surgical removal.
Celyad said FDA has accepted the company's Investigational New Drug application for CYAD-101, the first non-gene edited allogeneic clinical program. FDA has indicated that the Allo-SHRINK trial, evaluating the safety and clinical activity of CYAD-101 in patients with unresectable colorectal cancer in combination with standard chemotherapy, is allowed to proceed.
The China National Drug Administration approved Merck's Keytruda for the treatment of adult patients with unresectable or metastatic melanoma following failure of one prior line of therapy. This is the first approval of an anti-PD-1 therapy for advanced melanoma in China.
Bristol-Myers Squibb Co. and Tsinghua University have entered into a collaboration to discover therapeutic agents against novel targets for autoimmune diseases and cancers.
Lili Yang, a researcher at the UCLA Jonsson Comprehensive Cancer Center and the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA, has received a Quest Discovery Program award totaling approximately $1.4 million from the California Institute for Regenerative Medicine.
The global, randomized, phase III ALTA-1L trial met its primary endpoint at the first pre-specified interim analysis, with Alunbrig (brigatinib) demonstrating a statistically significant improvement in progression-free survival compared to crizotinib in adults with anaplastic lymphoma kinase-positive locally advanced or metastatic non-small cell lung cancer who had not received a prior ALK inhibitor.
Raymond DuBoisMichael PollakThe American Association for Cancer Research named Raymond DuBois and Michael Pollak as editors-in-chief of Cancer Prevention Research.
Jeff Walker, formerly a chief operating officer at Ohio State University, has been named COO of City of Hope.
Kenneth Manotti has been named senior vice president and Chief Development Officer at Memorial Sloan Kettering Cancer Center.
